The distribution, excretion, and possible metaboism of 14C-and/or 74As-cacodylic acid, an organoarsenical herbicide, was studied in rats following a single intravenous injection, intratracheal instillation or oral gavage. Male Sherman rats were dosed at levels ranging from 200 mg/kg to 120 ,g/kg. The extent and rate of lung absorption was greater than gastrointestinal absorption. Concentrations in the liver and whole blood were higher after peroral dosing than intravenous administration. Levels observed in plasma and other tissues were similar after all three routes following the absorptive phase. The percent dose found in the whole blood, red blood cells, and plasma was similar for all doses given by these routes. Less than 0.1½ of the administered dose was recovered as "4CO2 by any route at 24 hr after administration. Twenty-four hours after intravenous, intratracheal, and peroral administration, 71, 60, and 25%, respectively, was excreted in the urine. After intravenous administration of 200 mg/kg, sufficient 14C-cacodyllc acid was recovered in bile to account for the small amount excreted in the feces. Cacodylic acid is probably not metabolized to inorganic arsenic since the disposition of 14C and 74As-cacodylic acid were identical.
Introduction
The organoarsenical compound cacodylic acid (dimethylarsenic acid) is a nonselective herbicide used for control of weeds in noncrop areas, for cotton defoliation, for control of hardwood trees, and for suppression of bark beetles. Although the compound has been known for over 130 yr (1) , it was introduced into use as a herbicide only in 1958.
Methods
Young male Sherman strain rats were obtained from the Center for Disease Control, Atlanta, Georgia, and allowed to acclimatize in our animal quarters. Rats used in the study were determined to have normal weight gain and urinalysis [Combistix, Ames] . The rats weighed 280-380 g and were not fasted before treatment. Timepregnant CD rats (Charles Rivers, Inc.), were used in the placental transfer studies. 14C-and 74As-(half-life = 18 days) labeled cacodylic acid was synthesized by ICN Pharmaceuticals, Inc., Irvine, California. For the dual label experiments, aliquots of the 14C-and 74As-cacodylic acid were mixed. The specific activity of the 14C-and 74As-cacodylic acid was 10 mCi/mmole and 2 mCi/mmole, respectively. The radiochemical purity was reported and confirmed to be 99% by autoradiographic thin-layer chromatography.
Lung absorption of "4C-cacodylic acid was determined after the method of Enna and Schanker (6) . A PE 240 cannula was inserted as a guide between the fourth and fifth tracheal ring of chloral hydrate anesthetized rats to a depth of 6 mm. Dosing was accomplished through a smaller rubber cannula permitting passage only to the bifurcation of the trachea. A 100 ,ul portion of solution was administered for a dose of 78 mg/kg. The lungs and trachea were removed at 0, 5, 10, and 20 min and assayed for the amount of "4C-cacodylic equivalents remaining.
Peroral absorption kinetics were estimated by sacrificing 4 The following tissues were taken at selected times post administration: blood, heart, lung, spleen, kidney, liver, brain, testes and femoral muscle. Tissues were homogenized in 4 volumes of 0.85% saline per gram of tissue by using a Polytron homogenizer. A 250 ,ul aliquot sample was taken and digested in 1 ml of NCS (12 hr). Whole blood was collected in a 10 ml heparinized Vacutainer (Becton-Dickinson) from the abdominal aorta unless otherwise specified. Plasma and red blood cells were also harvested.
Both 14C and 74As isotopes were counted by using Beta counting techniques. 14C was evaluated at a 200 keV energy level and 74As at 700 keV energy level. 14C had a counting efficiency of 63% in the dual isotope program used. A theoretical efficiency of 74As of 38% was calculated based on the specific activity of 74As on the day of shipment from the supplier. Quench curves were constructed for the two isotopes individually and in combination. Any spillover in energy levels were considered. Known standards were run daily to correct for decay of 74As label. Radioarsenic was also determined by gamma spectrometry with an AutoGamma Scintillation Spectrometer (model 5986) and a Armac Scintillation Spectrometer (Packard Instrument Co.).
Whole blood volume and muscle mass was estimated by using published procedures: 0.055 x body weight0O99 (7), and 0.45 x body weight, respectively (8) . Plasma volumes were estimated from hematocrit values and the whole blood volume.
Results
The results of studies to determine lung and gastrointestinal absorption in the rat are shown in Figure 1. It can be seen that cacodylic acid is rapidly absorbed from the rat lung, with less than 5% remaining at 15 min. The half-time for absorption from the lung was found to be 2.2 min. The estimated half-time for peroral absorption was found to be 248 min. Data which compare whole blood and plasma distribution after intravenous and intratracheal instillation (200 mg/kg) are presented in Figure 5 . Although cacodylic acid is retained by the whole blood, it is rapidly eliminated from the plasma.
Since the plasma and whole blood data that have been presented were obtained after different levels of dosing, it is important to consider the matter of dose dependency. The data given in Table 2 address this issue. It can be seen that, with the exception of differences observed in levels in the liver and kidney at 15 min, no significant differences in the percent dose recovered in tissues or whole blood was observed after the administration of different dose levels. Data given in Table 3 indicate no significant differences in distribution after intravenous dosing in 14C-or 74As-labeled cacodylic acid.
The distribution of 14C-cacodylic acid (200 mg/kg) given intravenously is shown in Table 4 . Despite a rapid decline in tissue levels, whole blood tends to retain the 14C-label.
Although differences in whole blood levels after intravenous, intratracheal and peroral dosing were noted at 105 days (Fig. 4) , only three differences were noted in tissue levels at this time (Table 5 ).
The level of "4C-label in the spleen and kidney were higher after intratracheal instillation than after intravenous and higher levels were observed in the liver after peroral dosing when compared to intravenous.
The results presented in Table 6 indicate that three tissues, the spleen, kidney, and brain, have higher levels of 14C-label after multiple oral dosing.
Elimination and retention of cacodylic acid is shown in Table 7 . More cacodylic acid is retained after peroral administration than either intravenous or intracheal. The primary route of excretion after peroral dosing was fecal. Urinary excretion was lower after peroral dosing when compared with other routes.
The demethylation of 14C-cacodylic acid was evaluated. These results (Table 8) show that only a small fraction of the dose was evolved as 14CO2. It should be noted that an approximately 10-fold higher level of 14CO2 is eliminated by the peroral route when compared to other routes.
Approximately 1% of the dose administered intravenously was eliminated in the feces (Table 7) . bRats given 33 gg of "4C-cacodylic acid and 6.9 ug of 74As-cacodylic. cRats given 33 ,g of "C-cacodylic acid and 13.8 ,g of 74As-cacodylic acid. bSample not taken.
Experiments indicate that cacodylic acid is excreted in the bile (Table 9 ). All the data previously presented were obtained using the male Sherman rat as the model. Comparison of male and female rat tissue distribution of cacodylic acid at 1 and 72 hr after a single intravenous dose indicate no sex-related differences in concentration (Table 10 ). Cacodylic acid readily crosses the placenta (Table 11 ) 24 hr prior to parturition. Levels obtained in the whole blood of the fetus were not different than the maternal levels. Comparison with maternal tissue levels indicate differences in fetal tissue concentrations for brain and kidney but not liver.
Discussion
Cacodylic acid is absorbed from the rat lung and gastrointestinal tract. Plasma and whole blood curves obtained after intratracheal instillation are similar to those obtained after intravenous administration. The slower absorption of cacodylic acid after peroral administration is reflected in plasma and whole blood data. The estimated gastrointestinal half-time of 248 min agrees well with the 209 minute value reported by Hwang and Schanker (9) . The absorption after peroral and intracheal administration was 66 and 92%, respectively.
Cacodylic acid has a high affmity for the rat erythrocyte as evidenced by the rapid transfer from the serum fraction and the retention in the whole blood. It is well established that the rat differs from other tested species in its erythrocyte affinity for inorganic arsenic (8, 10) . The data presented in this study indicate a half-time of 90 days, which agrees well with the mean life of rat' red blood cell (8) .
Despite the fact that single dose peroral administration leads to higher whole blood levels than intra- tracheal and intravenous dosing and the administration of five daily doses produces whole blood levels four times as high as a single dose, at 105 days the percent of dose remaining in the whole blood after five daily peroral doses was less than that after a single dose by other routes. The total amount of cacodylic acid administered with the multiple dosing was approximately 80 ,ug compared to 40 ag given in a single dose. It is unlikely that reduced retention by the erythrocytes is related to absorption or cellular damage.
Cacodylic acid does not appear to be converted from organic to inorganic arsenical since the tissue distribution of 74As-and 14C-labeled cacodylic acid were not different. The present experimental results do not exclude possible changes in the valence states of the arsenic however.
High transient levels of cacodylic acid were found in muscle, kidneys, liver and lung. Lanz et al. (8) observed a similar distribution after administering carrier-free 74As. At 105 days after a single dose, detectable levels of cacodylic acid were found in all tissues evaluated. Highest concentrations were found in the lung and spleen. More radiolabel was recovered in the spleen and kidney of rats given cacodylic acid intratracheally than intravenously. More cacodylic acid was found in the liver of perorally dosed rats than those treated intravenously. The reasons for these differences are not understood at this time.
Despite lower whole blood levels found at 105 days after multiple oral dosing as compared to a single dose, a higher percent of the dose was recovered in the spleens, kidneys and brains after multiple dosing.
The excretion of cacodylic acid was very rapid, with more than 60% of the dose being excreted in the urine after intravenous and intratracheal administration and only minor amounts being excreted in the feces while after peroral dosing 25% of the dose was recovered in the urine and 31% in the feces. Secretion of the arsenical into the bile explains the small amount found in the feces after intravenous administration. Only minor amounts of label were evolved as 14C02.
Studies did not indicate any sex-related differences in the distribution of cacodylic acid. It was also found that cacodylic acid can pass the placental barrier just prior to parturition, achieving levels in the whole blood of the fetus comparable to the maternal animal.
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